Cosmos Health (COSM) vs EnerSyn Global (ESYN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cosmos Health (COSM) has outperformed EnerSyn Global (ESYN) over the past year, gaining 314.5% versus a loss of 26.5%. EnerSyn Global is the larger company by market cap ($37.4 million vs $14.1 million), about 2.6 times the size, while Cosmos Health is growing revenue faster (+19.9% vs -30.8%). Cosmos Health converts more of its revenue into profit, with a net margin of -29.3% versus -303.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COSM | ESYN |
|---|---|---|
| Share price | $2.81 | $1.11 |
| Market cap | $14.14M | $37.44M |
| 1-day change | -2.09% | -0.89% |
| YTD return | +464.26% | -25.50% |
| 1-year return | +314.45% | -26.49% |
| 5-year return | -17.60% | — |
| Forward P/E | 40.14 | — |
| EPS (TTM) | $-13.00 | $-0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $65.27M | $866.93K |
| Revenue growth (YoY) | +19.93% | -30.84% |
| Net income (latest FY) | $-19.14M | $-2.63M |
| Gross margin | 12.10% | 53.03% |
| Operating margin | -25.59% | — |
| Net margin | -29.33% | -303.44% |
| 52-week high | $14.36 | $2.81 |
| 52-week low | $2.20 | $0.88 |
| Distance from 52-week high | -80.43% | -60.50% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +60.14% | — |
| Average volume | 163.51K | 38.17K |
| Shares outstanding | 5.03M | 33.73M |
| Employees | 163 | 4 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EnerSyn Global is about 2.6 times larger than Cosmos Health by market value ($37.44M vs $14.14M).
- COSM has outperformed ESYN by 340.9 percentage points over the past year.
- Cosmos Health is more profitable, keeping -29.3 cents of every revenue dollar as net income versus -303.4 cents for EnerSyn Global.
- Cosmos Health grew revenue faster in its latest fiscal year (+19.93% vs -30.84%).
About Cosmos Health
COSM stock →Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus.
Health Care · Other Pharmaceuticals · 163 employees
About EnerSyn Global
ESYN stock →EnerSyn Global Inc. engages in the food and beverage business in Singapore and South Korea.
Health Care · Other Pharmaceuticals · 4 employees
COSM vs ESYN FAQ
Which is bigger, Cosmos Health or EnerSyn Global?
EnerSyn Global (ESYN) is larger, with a market capitalization of $37.44M compared with $14.14M for Cosmos Health (COSM).
Which stock has performed better over the past year, COSM or ESYN?
COSM returned +314.45% over the past 12 months, compared with -26.49% for ESYN (price return, excluding dividends). Past performance does not predict future results.
Are Cosmos Health and EnerSyn Global in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.